Search
forResearch 10 of 465
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Nonsteroidal Selective Androgen Receptors Modulators (SARMs): Designer Androgens with Flexible Structures Provide Clinical Promise
- Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Abstract P5-09-21: Selective androgen receptor modulators (SARMs): Enobosarm as targeted therapy for the treatment of androgen receptor-positive breast cancer
- A comprehensive investigation into the molecular mechanism responsible for selective androgen receptor (SARM) tissue-selectivity
- SARMS vs. anabolic steroids: comparative analysis of mechanisms, effects and health implications
- Pharmacology of anabolic steroids
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
Community 3
Learn
— no results
Try a deeper search in learn →